On Tuesday, 89bio Inc (NASDAQ: ETNB) opened higher 0.59% from the last session, before settling in for the closing price of $10.11. Price fluctuations for ETNB have ranged from $4.16 to $11.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 40.30% at the time writing. With a float of $141.29 million, this company’s outstanding shares have now reached $145.98 million.
Considering the fact that the conglomerate employs 93 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 42.86%, operating margin of -1920419.05%, and the pretax margin is -1837814.29%.
89bio Inc (ETNB) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of 89bio Inc is 3.21%, while institutional ownership is 106.18%. The most recent insider transaction that took place on Apr 15 ’25, was worth 91,208. In this transaction an insider of this company sold 15,329 shares at a rate of $5.95, taking the stock ownership to the 328,323 shares. Before that another transaction happened on Apr 15 ’25, when Company’s Officer proposed sale 15,329 for $5.95, making the entire transaction worth $91,171.
89bio Inc (ETNB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 40.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.04% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Check out the current performance indicators for 89bio Inc (ETNB). In the past quarter, the stock posted a quick ratio of 18.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -2.19 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
Compared to the last year’s volume of 2.25 million, its volume of 1.87 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 87.43%. Additionally, its Average True Range was 0.70.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 78.26%, which indicates a significant decrease from 92.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.09% in the past 14 days, which was lower than the 102.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.65, while its 200-day Moving Average is $8.26. Nevertheless, the first resistance level for the watch stands at $10.48 in the near term. At $10.80, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.20. If the price goes on to break the first support level at $9.76, it is likely to go to the next support level at $9.36. Should the price break the second support level, the third support level stands at $9.04.
89bio Inc (NASDAQ: ETNB) Key Stats
There are currently 145,984K shares outstanding in the company with a market cap of 1.48 billion. Presently, the company’s annual sales total 0 K according to its annual income of -367,080 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -71,280 K.
